Arthur Taveras - 11 Feb 2022 Form 4 Insider Report for X4 Pharmaceuticals, Inc (XFOR)

Role
Chief Scientific Officer
Signature
Derek M. Meisner, attorney-in-fact
Issuer symbol
XFOR
Transactions as of
11 Feb 2022
Net transactions value
$0
Form type
4
Filing time
14 Feb 2022, 15:21:14 UTC
Next filing
01 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XFOR Common Stock Tax liability $0 -928 -12% $0.000000 7,107 11 Feb 2022 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction was effected pursuant to a Rule 10b5-1 trading plan.
F2 Shares withheld by X4 Pharmaceuticals Inc. to satisfy taxes payable in connection with the vesting of previously awarded restricted stock units.
F3 Of the shares of common stock reported, 5,357 shares represent unvested restricted stock units.